ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.400
-0.020 (-4.74%)
At close: Dec 20, 2024, 4:00 PM
0.410
+0.010 (2.42%)
After-hours: Dec 20, 2024, 4:55 PM EST
ImmunoPrecise Antibodies Employees
As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.
Employees
101
Change (1Y)
-1
Growth (1Y)
-0.98%
Revenue / Employee
$171,013
Profits / Employee
-$198,247
Market Cap
13.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 101 | -1 | -0.98% |
| Apr 30, 2023 | 102 | 17 | 20.00% |
| Apr 30, 2022 | 85 | 12 | 16.44% |
| Apr 30, 2021 | 73 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProPhase Labs | 113 |
| BioXcel Therapeutics | 74 |
| Ekso Bionics Holdings | 72 |
| GlycoMimetics | 35 |
| Innovative Eyewear | 11 |
| Minerva Neurosciences | 9 |
IPA News
- 2 days ago - IPA to Present at The Microcap Conference 2025 - Accesswire
- 11 days ago - ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 - Business Wire
- 17 days ago - IPA to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - Business Wire
- 18 days ago - IPA to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025 on December 10, 2024 - Business Wire
- 5 weeks ago - $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies - Business Wire
- 6 weeks ago - ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - Business Wire
- 7 weeks ago - ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire